Powered by ZigaForm version 3.9.8.8

Application for Clinical Trials

Product Details

Title of Study: An investigator initiated and conducted, multicentre, international, double-blinded, placebo-controlled, parallel group, randomized controlled trial to determine the effect of more intensive blood pressure control provided by a fixed low-dose combination

Subtitle: Triple therapy prevention of Recurrent Intracerebral Disease Events Trial (TRIDENT)

Protocol; Version: ISRCTN76912190; Version 3

Phase of Study: Phase 3;

Study Type: grant aided study

Approval Date:

Applicant Name: Xcene Research Ltd

Address: 15, Ogundana Street, off Alen Avenue, Ikeja Lagos

Date of Application: 2019-07-16

Applicant Name: Xcene Research Ltd

Sponsor: The George Institute for Global Health

Address of Sponsor: Level 10,King George V Building, 83117 Missenden Rd, Campdown NSW 2050 Ausralia.

Trial Sites: 1. Neurology Unit, Dept. of Medicine, University of Ilorin Teaching Hospital (UITH), Ilorin. 2. Dept. of Medicine, Ahmadu Bello University Teaching Hospital (ABUTH), Zaria. 3. Neurology Unit, Dept. of Medicine, Lagos University Teaching Hospital (LUTH), I

Product Type: Drug

Status of Approval: Recruiting


Was this post helpful?